Oncotarget

Research Papers:

Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity

Janani Panneerselvam _, Manish Shanker, Jiankang Jin, Cynthia D. Branch, Ranganayaki Muralidharan, Yan D. Zhao, Sunil Chada, Anupama Munshi and Rajagopal Ramesh

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:16271-16286. https://doi.org/10.18632/oncotarget.3977

Metrics: PDF 868 views  |   HTML 1265 views  |   ?  


Abstract

Janani Panneerselvam1,4,*, Manish Shanker6,8,*, Jiankang Jin6,9,*, Cynthia D. Branch6,10, Ranganayaki Muralidharan1,4, Yan D. Zhao3,4, Sunil Chada7, Anupama Munshi2,4, Rajagopal Ramesh1,4,5

1Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

2Department of Radiation Oncology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

3Department of Biostatistics and Epidemiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

4Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

5Graduate Program in Biomedical Sciences, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

6Department of Thoracic & Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

7DNASolve, Houston, Texas, USA

8The University of Texas Dental School, Houston, Texas, USA

9Department of Gastrointestinal Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

10Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

*These authors have contributed equally to this work

Correspondence to:

Rajagopal Ramesh, e-mail: rajagopal-ramesh@ouhsc.edu

Keywords: IL-24, phosphorylation, lung cancer, cytokine

Received: March 27, 2015     Accepted: May 06, 2015     Published: May 18, 2015

ABSTRACT

Interleukin (IL)-24 is a tumor suppressor/cytokine gene that undergoes post-translational modifications (PTMs). Glycosylation and ubiquitination are important for IL-24 protein stabilization and degradation respectively. Little is known about IL-24 protein phosphorylation and its role in IL-24-mediated anti-tumor activities. In this study we conducted molecular studies to determine whether IL-24 phosphorylation is important for IL-24-mediated anti-cancer activity.

Human H1299 lung tumor cell line that was stably transfected with a doxycycline (DOX)-inducible (Tet-on) plasmid vector carrying the cDNA of IL-24-wild-type (IL-24wt) or IL-24 with all five phosphorylation sites replaced (IL-24mt) was used in the present study. Inhibition of tumor cell proliferation, cell migration and invasion, and induction of G2/M cell cycle arrest was observed in DOX-induced IL-24wt-expressing cells but not in IL-24mt-expressing cells. Secretion of IL-24mt protein was greatly reduced compared to IL-24wt protein. Further, IL-24wt and IL-24mt proteins markedly differed in their subcellular organelle localization. IL-24wt but not IL-24mt inhibited the AKT/mTOR signaling pathway. SiRNA-mediated AKT knockdown and overexpression of myristolyated AKT protein confirmed that IL-24wt but not IL-24mt mediated its anti-cancer activity by inhibiting the AKT signaling pathway.

Our results demonstrate that IL-24 phosphorylation is required for inhibiting the AKT/mTOR signaling pathway and exerting its anti-cancer activities.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3977